Laser-Activated Nanoglues for the prevention and control of surgical site infections
激光激活纳米胶用于预防和控制手术部位感染
基本信息
- 批准号:10249234
- 负责人:
- 金额:$ 22.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsAdhesivesAnimalsAnti-Bacterial AgentsAntibioticsBackBiochemicalBiological AssayBiomechanicsCenters for Disease Control and Prevention (U.S.)ClinicalCollagenColony-forming unitsCommunity HospitalsDermalDevelopmentDiabetes MellitusDiabetic mouseEncapsulatedEnzyme-Linked Immunosorbent AssayEvaluationFibroinsFormulationGluesGoalsGoldHistologyHospitalsImageImmune systemImmunocompetentImmunocompromised HostImmunohistochemistryInbred BALB C MiceInfectionInfection ControlInfection preventionInfiltrationInflammationIonsLaboratoriesLacerationLasersLeadLightMethodsMouse StrainsMusNatureObese MiceObesityOperative Surgical ProceduresPathologyPatient-Focused OutcomesPatientsPreventionPropertyProphylactic treatmentProtocols documentationRecoveryReportingResearchSilkSilverSiteSkinSourceSpine surgeryStaphylococcus aureusStaphylococcus aureus infectionSurgical Wound InfectionSurgical incisionsSurgical suturesTechniquesTechnologyTensile StrengthThickTimeTissuesUnited StatesVancomycinWorkWound modelsabsorptionangiogenesisantimicrobialbiomaterial compatibilitychronic woundclinical practiceclinical translationclinically relevantcombatcostcytokinedb/db mousediabeticdiabetic patientfluorescence imaginghealinghigh riskimprovedimproved outcomein vitro Assayinnovationmechanical propertiesmethicillin resistant Staphylococcus aureusmicroorganismmortalitymortality risknanoGoldnanomaterialsnanorodnovelnovel strategiespathogenpreclinical efficacypreventprophylacticrepairedresponsesealsoft tissuewoundwound closure
项目摘要
ABSTRACT
Up to 90 million surgical incisions are performed every year within the United States and despite improvements
in surgical techniques, administration of antimicrobial prophylaxis, and surveillance protocols, surgical site
infections (SSIs) remain a major clinical challenge. SSIs occur in 2-5% of patients undergoing surgery in the
United States alone, impact 300,000-500,000 lives each year, and are associated with a 2-11 times greater risk
of death compared to patients without SSIs. SSIs pose particularly serious challenges to patients with diabetes
and to those with compromised immune systems. The most common cause of SSI is Staphylococcus aureus
which occurs in 20% of SSIs among hospitals that report to the CDC and 37% among the community hospitals;
methicillin-resistant S. aureus (MRSA) is the most common pathogen in community hospitals. Current clinical
practices to treat incisions and traumatic lacerations include sutures, adhesives, tape, or staples with or without
antimicrobial incorporation. However, these technologies are susceptible to infection, wound dehiscence, and
poor or delayed biomechanical recoveries. Thus, there exists an urgent need to prevent and combat SSIs
efficiently in order to decrease patient mortality, time, and costs associated with recovery. Here, we propose the
development of novel laser-activated nanoglues (LANGs) for simultaneously sealing incisions together with the
ability to combat short-term and longer term or repeat SSIs. Laser sealing of incisions using LANGs will result in
a leak-proof seal throughout the incision, thereby preventing the infiltration of microorganisms into the wound.
Silver nanoprisms (AgNPs) in the LANGs absorb near infrared (NIR) light for rapid tissue sealing and can also
serve as sources of silver for antibacterial activity. Previous work in our laboratory has indicated that gold
nanorod-silk LANGs can be effectively used to seal incisions in mice and resist bacterial infiltration. The efficacy
for skin sealing and MRSA infection control of LANG formulations will be evaluated in immunocompetent,
immunodeficient, as well as diabetic and obese mice. LANGs will also be investigated as depots for longer-term
delivery of encapsulated antibiotics like vancomycin, which will serve to better resist longer-term and repeat
infections in susceptible hosts. Taken together, LANGs have tremendous translational potential as a multi-
faceted approach for effective tissue sealing and SSI control in surgery, and will see particular applicability in
immunodeficient and diabetic patients.
摘要
在美国,每年有多达9000万例手术切口,
在手术技术、抗菌预防管理和监测方案、手术部位
感染(SSI)仍然是主要的临床挑战。SSI发生在2-5%的手术患者中,
仅在美国,每年就影响30万至50万人的生命,并与2-11倍的风险有关。
与没有SSI的患者相比,SSI给糖尿病患者带来了特别严重的挑战
以及免疫系统受损的人。SSI最常见的原因是金黄色葡萄球菌
在向CDC报告的医院中,20%的SSI和37%的社区医院中发生;
耐甲氧西林表皮葡萄金黄色葡萄球菌(MRSA)是社区医院最常见的病原体。当前临床
治疗切口和创伤性撕裂伤的实践包括缝合、粘合剂、胶带或斯台普斯,
抗菌剂掺入。然而,这些技术易受感染、伤口裂开以及
生物力学恢复差或延迟。因此,迫切需要预防和打击SSI
有效地降低患者死亡率、时间和与恢复相关的成本。在这里,我们建议
开发新型激光激活纳米胶(LANG),用于同时密封切口,
打击短期和长期或重复SSI的能力。使用LANG激光密封切口将导致
在整个切口处进行防漏密封,从而防止微生物渗入伤口。
LANG中的银纳米棱镜(AgNP)吸收近红外(NIR)光以用于快速组织密封,并且还可以
用作抗菌活性的银源。我们实验室以前的工作表明,
纳米棒-丝LANG可以有效地用于密封小鼠的切口并抵抗细菌浸润。疗效
对于皮肤密封和MRSA感染控制,将在免疫活性,
免疫缺陷以及糖尿病和肥胖小鼠。LANG还将作为长期仓库进行调查
递送包封的抗生素,如万古霉素,这将有助于更好地抵抗长期和重复
感染易感宿主。总的来说,LANG作为一种多功能翻译工具具有巨大的翻译潜力,
在手术中有效组织凝闭和SSI控制的多面方法,并将特别适用于
免疫缺陷和糖尿病患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kaushal Rege其他文献
Kaushal Rege的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kaushal Rege', 18)}}的其他基金
Near Infrared Light Activated Adhesives for Nerve Repair
用于神经修复的近红外光激活粘合剂
- 批准号:
10436799 - 财政年份:2021
- 资助金额:
$ 22.57万 - 项目类别:
DEVELOPMENT OF NOVEL AMINOGLYCOSIDE POLYMERS AND NANOPARTICLES FOR NUCLEIC ACID DELIVERY IN CHRONIC WOUNDS
开发用于慢性伤口核酸输送的新型氨基糖苷聚合物和纳米颗粒
- 批准号:
10009545 - 财政年份:2020
- 资助金额:
$ 22.57万 - 项目类别:
Photothermal Nanocomposites for Tissue Repair
用于组织修复的光热纳米复合材料
- 批准号:
8945323 - 财政年份:2015
- 资助金额:
$ 22.57万 - 项目类别:
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods
使用组合和化学信息学方法设计 DNA 递送聚合物
- 批准号:
8602837 - 财政年份:2011
- 资助金额:
$ 22.57万 - 项目类别:
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods
使用组合和化学信息学方法设计 DNA 递送聚合物
- 批准号:
8212217 - 财政年份:2011
- 资助金额:
$ 22.57万 - 项目类别:
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods
使用组合和化学信息学方法设计 DNA 递送聚合物
- 批准号:
8416396 - 财政年份:2011
- 资助金额:
$ 22.57万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 22.57万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 22.57万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 22.57万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 22.57万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 22.57万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 22.57万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 22.57万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 22.57万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 22.57万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 22.57万 - 项目类别: